Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
Xuenian Chen,
Tongfei Shi,
Chao Yang,
Fangman Chen,
Xuan He,
Kunbao Zhang,
Hanze Hu,
Lulu Cai,
Kam W. Leong,
Dan Shao
Affiliations
Xuenian Chen
School of Biomedical Sciences and Engineering, South China University of Technology
Tongfei Shi
School of Biomedical Sciences and Engineering, South China University of Technology
Chao Yang
School of Biomedical Sciences and Engineering, South China University of Technology
Fangman Chen
School of Biomedical Sciences and Engineering, South China University of Technology
Xuan He
School of Biomedical Sciences and Engineering, South China University of Technology
Kunbao Zhang
School of Biomedical Sciences and Engineering, South China University of Technology
Hanze Hu
Department of Biomedical Engineering, Columbia University
Lulu Cai
Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China
Kam W. Leong
Department of Biomedical Engineering, Columbia University
Dan Shao
School of Biomedical Sciences and Engineering, South China University of Technology
